Leigang Jin

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 14

Top Topics

Top Venues

EMBO molecular medicine

Nature communications

Clinical and translational science

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Leigang Jin, Candela Diaz-Canestro, Yu Wang, Michael Andrew Tse, Aimin Xu
Exerkines and cardiometabolic benefits of exercise: from bench to clinic. EMBO molecular medicine 16 (3) (2024)
Zhe Huang, Hye Kyoung Sung, Xingqun Yan, Shiyu He, Leigang Jin, Qin Wang, Xuerui Wu, Henry H Hsu, Angelica Pignalosa, Kathryn Crawford, Gary Sweeney, Aimin Xu
The adiponectin-derived peptide ALY688 protects against the development of metabolic dysfunction-associated steatohepatitis. Clinical and translational science 17 (6) (2024)
Leigang Jin, Candela Diaz-Canestro, Yu Wang, Michael Andrew Tse, Aimin Xu
Exerkines and cardiometabolic benefits of exercise: from bench to clinic. EMBO molecular medicine 16 (3) (2024)
Leigang Jin, Candela Diaz-Canestro, Yu Wang, Michael Andrew Tse, Aimin Xu
Exerkines and cardiometabolic benefits of exercise: from bench to clinic. EMBO molecular medicine (2024)
Leigang Jin, Candela Diaz-Canestro, Yu Wang, Michael Andrew Tse, Aimin Xu
Exerkines and cardiometabolic benefits of exercise: from bench to clinic. EMBO molecular medicine 16 (3) (2024)
Zhe Huang, Hye Kyoung Sung, Xingqun Yan, Shiyu He, Leigang Jin, Qin Wang, Xuerui Wu, Henry H Hsu, Angelica Pignalosa, Kathryn Crawford, Gary Sweeney, Aimin Xu
The adiponectin-derived peptide ALY688 protects against the development of metabolic dysfunction-associated steatohepatitis. Clinical and translational science 17 (6) (2024)
Leigang Jin, Candela Diaz-Canestro, Yu Wang, Michael Andrew Tse, Aimin Xu
Exerkines and cardiometabolic benefits of exercise: from bench to clinic. EMBO molecular medicine (2024)
Leigang Jin, Candela Diaz-Canestro, Yu Wang, Michael Andrew Tse, Aimin Xu
Exerkines and cardiometabolic benefits of exercise: from bench to clinic. EMBO molecular medicine 16 (3) (2024)
Kang Chen, Lai Yee Cheong, Yuan Gao, Yaming Zhang, Tianshi Feng, Qin Wang, Leigang Jin, Eric Honoré, Karen Siu-Ling Lam, Weiping Wang, Hannah Xiaoyan Hui, Aimin Xu
Adipose-targeted triiodothyronine therapy counteracts obesity-related metabolic complications and atherosclerosis with negligible side effects. Nature communications 13 (1) (2022)
Kang Chen, Lai Yee Cheong, Yuan Gao, Yaming Zhang, Tianshi Feng, Qin Wang, Leigang Jin, Eric Honoré, Karen Siu-Ling Lam, Weiping Wang, Hannah Xiaoyan Hui, Aimin Xu
Adipose-targeted triiodothyronine therapy counteracts obesity-related metabolic complications and atherosclerosis with negligible side effects. Nature communications 13 (1) (2022)
Leiluo Geng, Boya Liao, Leigang Jin, Jiasui Yu, Xiaoyu Zhao, Yuntao Zhao, Ling Zhong, Baile Wang, Jiufeng Li, Jie Liu, Jin-Kui Yang, Wei Jia, Qizhou Lian, Aimin Xu
β-Klotho promotes glycolysis and glucose-stimulated insulin secretion via GP130. Nature metabolism 4 (5) (2022)
Kang Chen, Lai Yee Cheong, Yuan Gao, Yaming Zhang, Tianshi Feng, Qin Wang, Leigang Jin, Eric Honoré, Karen Siu-Ling Lam, Weiping Wang, Hannah Xiaoyan Hui, Aimin Xu
Adipose-targeted triiodothyronine therapy counteracts obesity-related metabolic complications and atherosclerosis with negligible side effects. Nature communications 13 (1) (2022)
Kang Chen, Lai Yee Cheong, Yuan Gao, Yaming Zhang, Tianshi Feng, Qin Wang, Leigang Jin, Eric Honoré, Karen Siu-Ling Lam, Weiping Wang, Hannah Xiaoyan Hui, Aimin Xu
Adipose-targeted triiodothyronine therapy counteracts obesity-related metabolic complications and atherosclerosis with negligible side effects. Nature communications 13 (1) (2022)
Ping Gu, Hannah Xiaoyan Hui, Qiantao Zheng, Yuan Gao, Leigang Jin, Weimin Jiang, Changsheng Zhou, Tianxia Liu, Yu Huang, Qing Liu, Tao Nie, Yanfang Wang, Yu Wang, Jianguo Zhao, Aimin Xu
Mitochondrial uncoupling protein 1 antagonizes atherosclerosis by blocking NLRP3 inflammasome-dependent interleukin-1β production. Science advances 7 (50) (2021)